SCHEMBL461346

SCHEMBL461346

CC(=O)OCC1COC(C)(C)O1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.56
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 1/20 0.39
TMEM97 Q5BJF2 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
PDK1 Q15118 1/20 0.38
HTR7 P34969 1/20 0.38
NLRP3 Q96P20 2/20 0.35
DGAT1 O75907 1/20 0.33
APP P05067 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
F10 P00742 1/20 0.33
NAMPT P43490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6575404 1.00 CA2 (0.56) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL6943821 0.89 CA2 (0.56) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL18395904 0.89 CA2 (0.56) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL12199638 0.89 CA2 (0.49) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL18395905 0.87 CA2 (0.54) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL15226054 0.87 CA2 (0.54) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL15225845 0.87 CA2 (0.54) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL6943823 0.87 CA2 (0.54) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL15225887 0.87 CA2 (0.54) CA2ALDH1A1NPSR1TMEM97SIGMAR1
SCHEMBL12513225 0.86 CA2 (0.53) CA2ALDH1A1NPSR1TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112063219-B Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2022-12-20 CN claimed
CN-112063219-A Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2020-12-11 CN claimed
CN-104995265-B Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2020-12-08 CN claimed
CN-110526894-A A method of solketal acetate is synthesized by glycerol UNIV ZHEJIANG TECHNOLOGY 2019-12-03 CN claimed
EP-2956513-B1 SOLVENT SYSTEM AND COMPOSITIONS THEREWITH RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) 2017-09-27 EP claimed
EP-2956513-A1 SOLVENT SYSTEM AND COMPOSITIONS THEREWITH Rhodia Poliamida E Especialidades Ltda (BR) 2015-12-23 EP claimed
US-20150361281-A1 SOLVENT SYSTEM AND COMPOSITIONS THEREWITH RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) 2015-12-17 US claimed
WO-2014125357-A1 SOLVENT SYSTEM AND COMPOSITIONS THEREWITH RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) 2014-08-21 WO claimed
WO-2014125313-A1 SOLVENT SYSTEMS AND COATING COMPOSITIONS THEREWITH RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) 2014-08-21 WO claimed
CN-103060064-B Magnesium alloy processing fluid special for processing of electronic accessory casing and preparation method thereof LANDNOK CHEMICAL GUANGZHOU CO LTD 2014-06-18 CN claimed
CN-103060064-A Magnesium alloy processing fluid special for processing of electronic accessory casing and preparation method thereof LANDNOK CHEMICAL GUANGZHOU CO LTD 2013-04-24 CN claimed
EP-1413627-A1 Enzymatic synthesis of (S)-1,2-O-isopropylidene glycerol PRIME EUROPEAN THERAPEUTICALS S.p.A., in abbreviated form EUTICALS S.p.A. (IT) 2004-04-28 EP claimed
CN-112063219-B Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2022-12-20 CN disclosed
CN-112899061-A Special water-based grinding fluid for hard alloy and preparation method thereof 自贡硬质合金有限责任公司 2021-06-04 CN disclosed
CN-112063219-A Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2020-12-11 CN disclosed
CN-104995265-B Solvent system and composition thereof 罗狄亚聚酰胺特殊品有限公司 2020-12-08 CN disclosed
EP-0272455-B1 3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-10 EP disclosed
US-5138064-A Chemical intermediate for penicillin derivative FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-11 US disclosed
US-4921852-A CARBAPENICILLINS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-01 US disclosed
EP-0272455-A1 3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361281-A1 SOLVENT SYSTEM AND COMPOSITIONS THEREWITH DECR1, SQLE, DECR2 CA2 2745/4885ALDH1A1 297/4885NPSR1 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.